Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Taimei Medical Technology Co's EBIT per Share for the
six
months ended in Dec. 2025 was €-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 52.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
FRA:A2V'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 20.7 Med: 36.75 Max: 52.8
Current: 52.8
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Zhejiang Taimei Medical Technology Co was 52.80% per year. The lowest was 20.70% per year. And the median was 36.75% per year.
FRA:A2V's 3-Year EBIT Growth Rate is ranked better than 87.38% of 523
companies
in the Healthcare Providers & Services industry
Industry Median: 12
vs FRA:A2V: 52.80
Zhejiang Taimei Medical Technology Co (FRA:A2V) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Zhejiang Taimei Medical Technology Co EBIT per Share Related Terms
Zhejiang Taimei Medical Technology Co EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Taimei Medical Technology Co EBIT per Share Chart
Zhejiang Taimei Medical Technology Co Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
EBIT per Share
-0.12
-0.10
-0.08
-0.05
-0.01
Zhejiang Taimei Medical Technology Co Semi-Annual Data
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a EBIT per Share of €-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. According to the industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #66 out of 523 companies in the Healthcare Providers & Services industry, placing it in the top 12.6%.
Is Zhejiang Taimei Medical Technology Co's EBIT per Share too high?
Zhejiang Taimei Medical Technology Co's current EBIT per Share is €-0.01. Based on the distribution chart, Zhejiang Taimei Medical Technology Co ranks #66 out of 523 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Zhejiang Taimei Medical Technology Co ranks #66 out of 523 companies for EBIT per Share. This places Zhejiang Taimei Medical Technology Co in the top 13% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Taimei Medical Technology Co's current EBIT per Share is €-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a current EBIT per Share of €-0.01. The current EBIT per Share is €-0.01. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (FRA:A2V), the current EBIT per Share is €-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score
Get the complete analysis for FRA:A2V
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A2V has been successfully added to your 
